Together, we’ll enhance your research with patient- and science-driven insights.
With Cerba Research as your partner for integrated clinical laboratory and diagnostic solutions, you direct the course of your complex trial. Team up with our top scientists: We’ll help you assess needs and generate early insights that optimize your protocol — from translational research to clinical through commercialization.
Reaching a global patient base can be challenging — but Cerba means certainty. Global access to industry-leading laboratories and demographically rich data drives the development of more advanced biomarker strategies and facilitates downstream decisions. Together, we can shape and advance your complex trial by leveraging Cerba HealthCare patient databases and our network of scientific experts spanning five continents. This intelligence — along with custom assays and on-target protocol advice — accelerates your program to market.
Mario Papillon
“Cerba Research is a group of motivated individuals committed to improving health via diagnostic services — and doing it in a very human way.”
Learn how our scientific experts, solutions, and global footprint accelerate your development timelines.
Our core values
These principles shape every decision we make.
Innovation
Since 1983, Cerba Research has been synonymous with innovation, and our identity is indivisible from our tireless pursuit of the breakthroughs that change patient lives.
Courage
Cerba Research’s strength is born of its flexibility and courage; as the needs of patients, clients, and employees change, we can only be as agile as we are courageous.
Commitment
Every conversation at Cerba research begins with a commitment to transparency, excellence and honesty, ensuring actions based on integrity and quality follow.
Empower
Cerba Research hires the best employees specifically so we can empower them to fulfill their full potential — this growth is the engine that drives the company forward.
Patients
The patient is at the heart of everything Cerba Research does and is our nonnegotiable first priority.